I write on behalf of the Biotechnology Industry Organization (BIO) to commend your sponsorship of, and express our support for, H.R. 5418, which would establish a pilot program in certain United States district courts to enhance the education and expertise of district court judges in the areas of patent law.
BIO and BIO members are urging lawmakers to enact a short-term extension of the MCM-PRV program while Congress is waiting to address a full reauthorization with PAHPA.
BIO has submitted comments to the Office of Science & Technology Policy on how regulations underpinning the Coordinated Framework for the Regulation of Biotechnology can better facilitate the use of biotechnology to stimulate the economy…
Dear Representative Issa:
I write on behalf of the Biotechnology Industry Organization (BIO) to commend your sponsorship of, and express our support for, H.R. 5418, which would establish a pilot program in certain United States district courts to enhance the education and expertise of district court judges in the areas of patent law.